Back to Search
Start Over
The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?
- Source :
- Cellular & Molecular Life Sciences; Jan2016, Vol. 73 Issue 1, p129-145, 17p, 2 Diagrams, 4 Charts
- Publication Year :
- 2016
-
Abstract
- The Helicase-like Transcription Factor (HLTF) belongs to the SWI/SNF family of proteins involved in chromatin remodeling. In addition to its role in gene transcription, HLTF has been implicated in DNA repair, which suggests that this protein acts as a tumor suppressor. Accumulating evidence indicates that HLTF expression is altered in various cancers via two mechanisms: gene silencing through promoter hypermethylation or alternative mRNA splicing, which leads to the expression of truncated proteins that lack DNA repair domains. In either case, the alteration of HLTF expression in cancer has a poor prognosis. In this review, we gathered published clinical and molecular data on HLTF. Our purposes are (a) to address whether HLTF alterations could be considered as cancer drivers or passengers and (b) to determine whether its different functions (transcription or DNA repair) could be diverted in clonal selection during cancer progression. [ABSTRACT FROM AUTHOR]
- Subjects :
- HELICASES
TRANSCRIPTION factors
TUMOR suppressor proteins
CHROMATIN
DNA repair
Subjects
Details
- Language :
- English
- ISSN :
- 1420682X
- Volume :
- 73
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Cellular & Molecular Life Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 112062728
- Full Text :
- https://doi.org/10.1007/s00018-015-2060-6